ArticleTranslational lung cancer research2025

Efficacy and safety of first-generation epidermal growth factor receptor tyrosine kinase inhibitors in retreatment of patients without T790M.

Juwhan Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.